SEC Form 4 · Updated Daily
TVRD
— TVARDI THERAPEUTICS, INC. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| CSL LTD | 10%+ Owner | 7,396,770 | 2022-08-09 | — |
| Vifor (International) Ltd | 10%+ Owner | 7,396,770 | 2021-10-20 | — |
| Vifor Pharma Ltd. | 10%+ Owner | 7,396,770 | 2021-10-20 | — |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 10%+ Owner | 7,396,770 | 2021-10-20 | — |
| LESCHLY MARK | 10%+ Owner | 3,568,057 | 2017-03-31 | P |
| RHO Ventures VI LP | 10%+ Owner | 3,568,057 | 2017-03-31 | P |
| KAIROUZ HABIB | 10%+ Owner | 3,568,057 | 2017-03-31 | P |
| RMV VI, L.L.C. | 10%+ Owner | 3,568,057 | 2017-03-31 | P |
| RUCH JOSHUA | 10%+ Owner | 3,568,057 | 2017-03-31 | P |
| Rho Capital Partners LLC | 10%+ Owner | 3,568,057 | 2017-03-31 | P |
| HURWITZ EDWARD | Director | 1,753,447 | 2014-02-05 | P |
| ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC | 10%+ Owner | 1,753,447 | 2014-02-05 | P |
| ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG | 10%+ Owner | 1,753,447 | 2014-02-05 | P |
| PENHOET EDWARD | 10%+ Owner | 1,753,447 | 2014-02-05 | P |
| ALTA BIOPHARMA MANAGEMENT III LLC | 10%+ Owner | 1,753,447 | 2014-02-05 | P |
| CHAMPSI FARAH | 10%+ Owner | 1,753,447 | 2014-02-05 | P |
| ALTA BIOPHARMA PARTNERS III LP | 10%+ Owner | 1,753,447 | 2014-02-05 | P |
| Moller Charles Ph.D. | Director | 1,576,404 | 2014-02-05 | C |
| Slagel Dean | Director | 1,085,200 | 2017-06-29 | S |
| CHALMERS DEREK T | Director · Officer | 991,405 | 2021-09-07 | S |
| VOGELBAUM MARTIN | Director | 411,007 | 2024-06-04 | A |
| Lewis Michael E | Officer | 314,988 | 2016-01-26 | S |
| Wirk Shaheen | Director | 263,164 | 2025-04-15 | A |
| Shiff Susan Ph.D. | Director | 202,085 | 2024-06-04 | A |
| HALL WALLACE L JR | Director | 202,044 | 2025-04-15 | A |
| Ives Jeffrey L. | Director | 198,485 | 2024-06-04 | A |
| von Moltke Lisa | Officer | 183,009 | 2024-06-04 | A |
| Menzaghi Frederique Ph.D. | Officer | 167,247 | 2024-02-01 | A |
| Boudreau Helen M | Director | 150,647 | 2024-06-04 | A |
| BAINS HARRISON M JR | Director | 57,438 | 2023-06-01 | A |
| Goncalves Joana | Officer | 53,365 | 2024-04-05 | S |
| Schoell Josef | Officer | 50,000 | 2017-07-26 | M |
| Reilly Thomas Charles | Officer | 37,811 | 2022-03-03 | S |
| Mohindru Mani | Director | 22,196 | 2019-12-02 | A |
| Makara Richard | Officer | 13,583 | 2022-06-15 | A |
| Posner Christopher | Director · Officer | 13,109 | 2025-02-28 | S |
| Maynard Ryan D | Director | 8,012 | 2023-02-08 | S |
| Terrillion Scott | Officer | 7,190 | 2025-02-28 | S |
| Stauffer Joseph William | Officer | 2,970 | 2018-10-17 | S |
| Tweardy Samuel David | 10%+ Owner | 0 | 2025-07-07 | J |
| Medve Robert | Officer | 0 | 2014-06-17 | — |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-06-09 | WYZGA MICHAEL S | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-06-09 | HALL WALLACE L JR | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-06-09 | Shah Sujal | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-06-09 | Smith Cynthia | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-06-09 | Shiff Susan Ph.D. | Grant / award (derivative) | 6,000 | $0.00 | 6,000 |
| 2026-01-29 | Alibhai Imran Nizamudin | Grant / award (derivative) | 115,000 | $0.00 | 115,000 |
| 2026-01-29 | Kauh John Saewook M.D. | Grant / award (derivative) | 45,000 | $0.00 | 45,000 |
| 2026-01-29 | Conn Avi Daniel | Grant / award (derivative) | 45,000 | $0.00 | 45,000 |
| 2026-01-29 | O'Brien Stephen Paul | Grant / award (derivative) | 15,000 | $0.00 | 15,000 |
| 2025-12-16 | Alibhai Imran Nizamudin | Grant / award (derivative) | 47,500 | $0.00 | 47,500 |
| 2025-12-16 | Conn Avi Daniel | Grant / award (derivative) | 17,500 | $0.00 | 17,500 |
| 2025-12-16 | Kauh John Saewook M.D. | Grant / award (derivative) | 17,500 | $0.00 | 17,500 |
| 2025-12-16 | O'Brien Stephen Paul | Grant / award (derivative) | 4,000 | $0.00 | 4,000 |
| 2025-07-07 | Tweardy Samuel David | J | 315,658 | $0.00 | 0 |
| 2025-04-17 | HALL WALLACE L JR | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Shah Sujal | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Smith Cynthia | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | WYZGA MICHAEL S | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Wirk Shaheen | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Shiff Susan Ph.D. | Grant / award (derivative) | 12,000 | $0.00 | 12,000 |
| 2025-04-17 | Alibhai Imran Nizamudin | Grant / award (derivative) | 182,320 | $0.00 | 182,320 |
| 2025-04-17 | Kauh John Saewook M.D. | Grant / award (derivative) | 36,210 | $0.00 | 36,210 |
| 2025-04-17 | Conn Avi Daniel | Grant / award (derivative) | 43,547 | $0.00 | 43,547 |
| 2025-04-17 | Chen Yixin | Grant / award (derivative) | 7,213 | $0.00 | 7,213 |
| 2025-04-17 | O'Brien Stephen Paul | Grant / award (derivative) | 7,213 | $0.00 | 7,213 |
| 2025-04-17 | Larson Jeffrey Leroy | Grant / award (derivative) | 10,820 | $0.00 | 10,820 |
| 2025-04-15 | Tweardy Samuel David | — | — | — | 315,658 |
| 2025-04-15 | Tweardy Samuel David | — | — | — | 315,658 |
| 2025-04-15 | Tweardy Samuel David | — | — | — | 315,658 |
| 2025-04-15 | Alibhai Imran Nizamudin | Grant / award (derivative) | 207,881 | — | 207,881 |
| 2025-04-15 | Alibhai Imran Nizamudin | Grant / award (derivative) | 160,940 | — | 160,940 |
| 2025-04-15 | Alibhai Imran Nizamudin | Grant / award (derivative) | 2,011 | — | 2,011 |
| 2025-04-15 | Conn Avi Daniel | Grant / award (derivative) | 89,053 | — | 89,053 |
| 2025-04-15 | Larson Jeffrey Leroy | Grant / award (derivative) | 5,364 | — | 5,364 |
| 2025-04-15 | Larson Jeffrey Leroy | Grant / award (derivative) | 16,764 | — | 16,764 |
| 2025-04-15 | Shah Sujal | Grant / award (derivative) | 8,047 | — | 8,047 |
| 2025-04-15 | Shah Sujal | Grant / award (derivative) | 10,394 | — | 10,394 |
| 2025-04-15 | Wirk Shaheen | Grant / award (derivative) | 2,011 | — | 2,011 |
| 2025-04-15 | Wirk Shaheen | J | 263,164 | — | 263,164 |
| 2025-04-15 | Wirk Shaheen | J | 176,030 | — | 176,030 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.